Tatra G, Polak S, Nasr F
Geburtshilfe Frauenheilkd. 1981 May;41(5):359-61. doi: 10.1055/s-2008-1036810.
Serum levels of SP-1 and beta HCG as Trophoblastic Markers were measured in 31 women operated on suspected ectopic pregnancy. In all 24 patients with tubal pregnancy SP-1 levels estimated by enzyme immunoassay Enzygnost were higher than 5 ng/ml, whereas SP-1 levels in 7 cases with benign ovarian cysts were less than 2 ng/ml. Beta-HCG in serum was analysed by radioimmunoassay (Serono-Biodata): in cases with ectopic pregnancy serum levels were between 113 mIU/ml and 1040 mIU/ml, in the 7 nonpregnant cases the highest concentration was 7 mIU/ml. There was no correlation between serum concentration of SP-1 and beta-HCG (r = 0,571). In view of clinical practice preference is given to estimation of SP-1 by enzyme immunoassay over estimation of beta-HCG by radioimmunoassay, the reasons are discussed.
对31例疑似异位妊娠手术的女性测定了作为滋养层标志物的血清SP-1和β-HCG水平。在所有24例输卵管妊娠患者中,通过酶免疫测定法(Enzygnost)估计的SP-1水平高于5 ng/ml,而7例良性卵巢囊肿患者的SP-1水平低于2 ng/ml。血清β-HCG通过放射免疫测定法(Serono-Biodata)分析:异位妊娠患者血清水平在113 mIU/ml至1040 mIU/ml之间,7例未孕患者中最高浓度为7 mIU/ml。SP-1血清浓度与β-HCG之间无相关性(r = 0.571)。鉴于临床实践,酶免疫测定法测定SP-1优于放射免疫测定法测定β-HCG,并讨论了原因。